Anti-Human/Mouse CD266 (TWEAK Receptor) Purified

Also known as: TNFRSF12A, Fibroblast growth factor-inducible 14, Fn14

Clone: ITEM-2

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 14-9016

Cat. No. Size
14-9016-80 25 ug
14-9016-82 100 ug

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Human/Mouse CD266 (TWEAK Receptor) Purified.

Click on image to view more information.

More Views

  • Data for Anti-Human/Mouse CD266 (TWEAK Receptor) Purified.
Description

Description: The ITEM-2 antibody reacts with human TWEAK Receptor/Fn14 (fibroblast growth factor-inducable 14 kDa protein) and cross-reacts with the mouse antigen. Fn14 is distantly related to the TNFR family, containing one cysteine-rich domain in the extracellular region and a TNFR-associated factor binding domain but does not contain a death domain (DD) cytoplasmic region. Fn14 plays a role in TWEAK-induced endothelial cell migration, proliferation, and angiogenesis. TWEAK-induced cell death via Fn14 includes both apoptosis and necrosis and can be blocked by an anti-TWEAK antibody, CARL-1 (Cat. No. 16-9915). Fn14 is expressed on HUVEC and in some cancer tissues but not on freshly isolated PBMCs. Fn14 mRNA expression has been identified during liver regeneration. In the mouse, Fn14 is reported to be constitutively expressed by Colon 26 cell line. ITEM-2 is reported to act as an antagonist in in vitro functional assays.

Details
Host Mouse
Isotype IgA, kappa
Reactivity Human, Mouse
Conjugate Purified
Reported Applications Flow Cytometric Analysis, Functional Assays
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
References

References: Moreno JA, Muñoz-García B, Martín-Ventura JL, Madrigal-Matute J, Orbe J, Páramo JA, Ortega L, Egido J, Blanco-Colio LM The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis. Atherosclerosis. 2009 Nov;207(1):103-10 (ITEM-2, FA, PubMed)

Nakayama, M., K. Ishidoh, Y. Kojima, N. Harada, E. Kominami, K. Okumura, H. Yagita. Fibroblast Growth Factor-Inducible 14 Mediates Multiple Pathways of TWEAK-Induced Cell Death. J Immunol. 2003, 170: 341-348.

Harada N., M. Nakayama, H. Nakano, Y. Fukuchi, H. Yagita, K. Okumura. Pro-inflammatory Effect of TWEAK/Fn14 Interaction on Human Umbilical Vein Endothelial Cells. Biochem Biophys Res Commun, 2002, 299(3):488-93.

Nakayama M, K. Ishidoh, N. Kayagaki, Y. Kojima, N. Yamaguchi, H. Nakano, E. Kominami, K. Okumura, H. Yagita. Multiple pathways of TWEAK-induced cell death. J Immunol, 2002, 168(2):734-43